🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bone Marrow

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia NCT06956755n/a1 site📍 Rouen Groupe Francophone des Myelodysplasies Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984NA1 site📍 Parma Azienda Ospedaliero-Universitaria di Parma · Tests: Genetic, molecular and/or omics analyses Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT00801489Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate, Gemtuzumab Ozogamicin Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples NCT04251078n/a1 site📍 Badalona Josep Carreras Leukaemia Research Institute Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site📍 Memphis St. Jude Children's Research Hospital A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. NCT06566742Phase 22 sites📍 Miami📍 Houston M.D. Anderson Cancer Center · Tests: Olutasidenib Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial NCT06355583Phase 28 sites📍 Birmingham📍 Leeds📍 London Imperial College London · Tests: EBX-102, Placebo Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-co… OSTEOMICS: Identifying Regulators of Bone Homeostasis NCT05732870n/a8 sites📍 London📍 London📍 London Relation Therapeutics · Tests: Relevant orthopaedic surgery A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration NCT06074783Phase 1, Phase 21 site📍 Nassau Cellcolabs Clinical LTD. · Tests: Human Allogeneic Bone-Marrow (BM) -Derived Mesenchymal Stromal Cells (MSCs) Product (StromaForte) Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT NCT07677306Phase 21 site📍 Beijing Peking University People's Hospital · Tests: RTC conditioning regimen and Modified Bu/Cy conditioning regimen Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML NCT05807932Phase 1, Phase 26 sites📍 Aachen📍 Düsseldorf📍 Cologne Heinrich-Heine University, Duesseldorf · Tests: Venetoclax, Amsacrine, Ara-C, Tacrolimus, Mycophenolate Mofetil Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant NCT06315309Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: ATG Combined with Tacrolimus and Mini Methotrexate Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients NCT06918834Phase 25 sites📍 Beijin📍 Zhengzhou📍 Jinan Institute of Hematology & Blood Diseases Hospital, China · Tests: Immediate HSCT Group, Bridging Therapy Group Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant NCT06543381Phase 12 sites📍 Duarte📍 Cleveland City of Hope Medical Center · Tests: Biospecimen Collection, Olutasidenib Bone Marrow Injection in Fracture of Femoral Neck NCT07808294NA1 site📍 Idlib Yaser Alkanash · Tests: Anatomical reduction and fixation with bone marrow injection, Anatomical reduction with Fixation IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2) NCT06647862Phase 343 sites📍 Hefei📍 Beijing📍 Chongqing ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Tests: IMM01, Azacitidine, Placebo Asian Myeloproliferative Neoplasm (MPN) Registry NCT05882773n/a1 site📍 Hong Kong The University of Hong Kong Forced Oscillatory Technique for Bronchiolitis Obliterans Syndrome After Allogeneic Bone Marrow Transplantation NCT07730931NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: FOT - Forced Oscillation Technique A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) NCT06782373Phase 239 sites📍 Scottsdale📍 Boston📍 Rochester Swedish Orphan Biovitrum · Tests: Pacritinib, Placebo Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia NCT03896269Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Liposome-encapsulated Daunorubicin-Cytarabine Cord Blood Transplantation in Children and Young Adults With Blood Cancer NCT07566377Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Cord Blood Units, Total Body Irradiation, Cyclophosphamide, Fludarabine, Clofarabine A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome NCT05027945Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Allogeneic HSCT, Busulfan test dose, Mycophenolate mofetil (MMF), Tacrolimus, Busulfan Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites📍 Birmingham📍 Irvine📍 Los Angeles Incyte Corporation · Tests: INCA036978, Standard disease-directed therapy Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia NCT03263572Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Cytarabine, Methotrexate, Ponatinib Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear NCT03909139n/a1 site📍 Boston Massachusetts General Hospital · Tests: BMAC MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera NCT04116502Phase 355 sites📍 Aberdeen📍 Bath📍 Belfast University of Birmingham · Tests: Ruxolitinib, Hydroxycarbamide, Interferon-Alpha To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects NCT07480824Phase 12 sites📍 Luoyang📍 Jinan Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQ05105
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy